[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334909-105":59,"doc-detail-334909-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","correlation-analysis-of-genetic-mutations-and-galectin-levels-in-breast-cancer-patients","Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients","","Galectins function as innate immune regulators linked to cancer progression. This study evaluates whether correlations between mutated cancer-critical genes and galectin concentrations in breast cancer patients can support biomarker use and identify candidate therapy targets. Serum galectin-1, -3, and -9 were measured by ELISA in 71 patient samples, while hotspot gene mutations were profiled using multiplex PCR, followed by multiple statistical tests. Results show KIT mutations correlate with higher galectin-9, subtype-specific effects for FLT3 and TP53, and higher galectin-3 with invasive ductal carcinoma and combined TP53/PIK3CA mutations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/correlation-analysis-of-genetic-mutations-and-galectin-levels-in-breast-cancer-patients/334909/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/correlation-analysis-of-genetic-mutations-and-galectin-levels-in-breast-cancer-patients/334909.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on breast cancer patients?","Question",{"text":112,"@type":113},"To investigate correlations between mutated cancer-critical genes and galectin levels, assessing whether galectins and genetic profiles can serve as biomarkers and potential therapy targets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were gene mutations and galectin levels measured?",{"text":117,"@type":113},"Hotspot mutations in cancer-critical genes were determined using multiplex PCR, and galectin-1, -3, and -9 levels in patient sera were analyzed using ELISA.",{"name":119,"@type":110,"acceptedAnswer":120},"Which mutation–galectin relationships were reported?",{"text":121,"@type":113},"KIT mutations correlated with elevated serum galectin-9. In Luminal A patients, FLT3 mutations correlated with lower galectin-1 and -9, while TP53 mutations correlated with higher galectin-3. Combined TP53 and PIK3CA mutations were associated with elevated galectin-3.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334909,1790161626,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":4},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Article  \nCorrelation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients  \nElla G. Markalunas 1, David H. Arnold 2, Avery T. Funkhouser 2, Julie C. Martin 3, Michael Shtutman 4, W. Jeffery Edenfield 3,5 and Anna V. Blenda 2,3, *  \nCitation: Markalunas, E.G.; Arnold, D.H.; Funkhouser, A.T.; Martin, J.C.; Shtutman, M.; Edenfield, W.J.; Blenda, A.V. Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients. Genes 2024, 15, 818. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)genes15060818  \nAcademic Editor: Sudheer Kumar Gara  \nReceived: 27 April 2024  \nRevised: 5 June 2024  \nAccepted: 13 June 2024  \nPublished: 20 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Public Health, Brown University, Providence, RI 02912, USA; [ella_markalunas@brown.edu](ella_markalunas@brown.edu)  \n2 Department of Biomedical Sciences, University of South Carolina School of Medicine Greenville, Greenville, SC 29605, USA; [dharnold@email.sc.edu](dharnold@email.sc.edu) (D.H.A.); [averytf@email.sc.edu](averytf@email.sc.edu) (A.T.F.)  \n3 Prisma Health Cancer Institute, Prisma Health, Greenville, SC 29605, USA;  \n[julie.martin@prismahealth.org](julie.martin@prismahealth.org) (J.C.M.); [jeffery.edenfield@prismahealth.org](jeffery.edenfield@prismahealth.org) (W.J.E.)  \n4 Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, Columbia, SC 29208, USA; [shtutmanm@cop.sc.edu](shtutmanm@cop.sc.edu)  \n5 Department of Medicine, University of South Carolina School of Medicine Greenville, Greenville, SC 29605, USA  \n* Correspondence: [ablenda@greenvillemed.sc.edu](ablenda@greenvillemed.sc.edu)  \nAbstract: Galectins are innate immune system regulators associated with disease progression in cancer. This paper aims to investigate the correlation between mutated cancer-critical genes and galectin levels in breast cancer patients to determine whether galectins and genetic profiles can be used as biomarkers for disease and potential therapy targets. Prisma Health Cancer Institute’s Biorepository provided seventy-one breast cancer samples, including all four stages spanning the major molecular subtypes and histologies. Hotspot mutation statuses of cancer-critical genes were determined using multiplex PCR in tumor samples from the same patients by Precision Genetics and the University of South Carolina Functional Genomics Core Facility. The galectin-1, -3, and-9 levels in patients’ sera were analyzed using Enzyme-linked Immunosorbent Assay (ELISA) . An analysis was performed using JMP software to compare mean and median serum galectin levels between samples with and without specific cancer-critical genes, including pooled t-test, Wilcoxon Rank Sum Test, ANOVA, and Steel Dwass Test (α = 0.05) . Our analysis indicates that KIT mutations correlate with elevated serum levels of galectin-9 in patients with breast cancer. In patients with Luminal A subtype, FLT3 mutation correlates with lower serum galectin-1 and-9 levels and TP53 mutations correlate with higher serum galectin-3 levels. Patients with invasive ductal carcinoma had significantly higher serum galectin-3 levels than patients with ductal carcinoma in situ. Patients with both TP53 and PIK3CA mutations exhibit elevated serum galectin-3 levels, while patients with one or neither mutation show no significant difference in serum galectin-3 levels. In addition, metastatic breast cancer samples were more likely to have a KIT or PIK3CA mutation compared to primary breast cancer samples. The relationship between genetic mutations and galectin levels has the pote","cbCaigphIlCTEJcw","https://ap.wps.com/l/cbCaigphIlCTEJcw","pdf",428470,16,"English","# Introduction\n# Materials and Methods\n# Results\n# Discussion","[{\"question\":\"What is the main goal of the study on breast cancer patients?\",\"answer\":\"To investigate correlations between mutated cancer-critical genes and galectin levels, assessing whether galectins and genetic profiles can serve as biomarkers and potential therapy targets.\"},{\"question\":\"How were gene mutations and galectin levels measured?\",\"answer\":\"Hotspot mutations in cancer-critical genes were determined using multiplex PCR, and galectin-1, -3, and -9 levels in patient sera were analyzed using ELISA.\"},{\"question\":\"Which mutation–galectin relationships were reported?\",\"answer\":\"KIT mutations correlated with elevated serum galectin-9. In Luminal A patients, FLT3 mutations correlated with lower galectin-1 and -9, while TP53 mutations correlated with higher galectin-3. Combined TP53 and PIK3CA mutations were associated with elevated galectin-3.\"}]","Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients | PDF",1790008798]